Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.

Suppr

超能文献

作者信息

Rahman Y E, Rosenthal M W, Cerny E A, Moretti E S

出版信息

J Lab Clin Med. 1974 Apr;83(4):640-7.

PMID:4206355

Abstract

摘要

相似文献

Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.

J Lab Clin Med. 1974 Apr;83(4):640-7.

Tissue distribution of EDTA encapsulated within liposomes of varying surface properties.

Biochim Biophys Acta. 1975 Sep 2;401(3):336-48. doi: 10.1016/0005-2736(75)90234-5.

Distribution and retention of 169-YbCl3, 169-Yb-EDTA and 169-Yb-DTPA injected intravenously in the rat.

Acta Physiol Pol. 1975 Mar-Apr;26(2):205-12.

Intracellular plutonium: removal by liposome-encapsulated chelating agent.细胞内钚：通过脂质体包裹的螯合剂去除

Science. 1973 Apr 20;180(4083):300-2. doi: 10.1126/science.180.4083.300.

Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.通过脂质体包裹N,N'-双[2-羟基苄基]-乙二胺-N,N'-二乙酸（HBED）改善网状内皮系统的铁清除。与去铁胺的比较。

J Lab Clin Med. 1983 May;101(5):806-16.

51Cr EDTA and 51Cr DTPA: renal diagnostic agents influence of the method of preparation on their biological behaviour.

Int Z Klin Pharmakol Ther Toxikol. 1970 Jul;3(3):238-44.

[Metabolism and toxicity of therapeutic chelating agents. 4. Excretion and metabolic degradation of EDTA and DTPA].[治疗性螯合剂的代谢与毒性。4. 乙二胺四乙酸（EDTA）和二乙烯三胺五乙酸（DTPA）的排泄与代谢降解]

Strahlentherapie. 1968 Nov;136(5):604-8.

[C-14 fusidin levels in mice following single intravenous administration].单次静脉给药后小鼠体内的C-14夫西地酸水平

Antibiotiki. 1971 Nov;16(11):999-1003.

[Characteristics of the metabolism of Na3Ca-14C-DTPA encapsulated in liposomes].[包裹于脂质体中的 Na3Ca-14C-DTPA 的代谢特征]

Dokl Akad Nauk SSSR. 1982;266(3):734-7.

[Comparative organ distribution of various sizes of liposomes during their intravenous administration].[不同大小脂质体静脉给药后的比较性器官分布]

Vopr Med Khim. 1984 Jan-Feb;30(1):37-41.

引用本文的文献

Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine.纳米颗粒与纳米材料：从药学与医学角度的综述

Pharmaceutics. 2025 May 16;17(5):655. doi: 10.3390/pharmaceutics17050655.

Liposomal systems as carriers for bioactive compounds.脂质体系统作为生物活性化合物的载体。

Biophys Rev. 2015 Dec;7(4):391-397. doi: 10.1007/s12551-015-0180-8. Epub 2015 Oct 10.

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.小阳离子 DDA:TDB 脂质体作为蛋白疫苗佐剂，在诱导细胞和体液应答方面不需要 TLR 激动剂。

PLoS One. 2012;7(3):e34255. doi: 10.1371/journal.pone.0034255. Epub 2012 Mar 28.

Liposome technology for industrial purposes.用于工业目的的脂质体技术。

J Drug Deliv. 2011;2011:591325. doi: 10.1155/2011/591325. Epub 2010 Dec 5.

Suppression of liver uptake of liposomes by dextran sulfate 500.硫酸葡聚糖500对脂质体肝脏摄取的抑制作用

Proc Natl Acad Sci U S A. 1983 Nov;80(21):6518-22. doi: 10.1073/pnas.80.21.6518.

Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.

Pharm Res. 1989 Jul;6(7):601-7. doi: 10.1023/a:1015905615404.

Liposomal retention of a modified anti-inflammatory steroid.一种改良抗炎类固醇的脂质体保留

Biochem J. 1976 Aug 15;158(2):473-6. doi: 10.1042/bj1580473.

Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal.含有螯合剂的脂质体。细胞穿透及金属去除的可能机制。

J Cell Biol. 1975 Apr;65(1):112-22. doi: 10.1083/jcb.65.1.112.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验